These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10979113)

  • 21. Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia.
    King JM; Crouse JR; Terry JG; Morgan TM; Spray BJ; Miller NE
    Am J Med; 1994 Oct; 97(4):323-31. PubMed ID: 7942933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes.
    Pan J; Lin M; Kesala RL; Van J; Charles MA
    Diabetes Obes Metab; 2002 Jul; 4(4):255-61. PubMed ID: 12099974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients.
    Morgan JM; Capuzzi DM; Guyton JR
    Am J Cardiol; 1998 Dec; 82(12A):29U-34U; discussion 39U-41U. PubMed ID: 9915660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2.
    Taylor AJ; Zhu D; Sullenberger LE; Lee HJ; Lee JK; Grace KA
    Vasc Health Risk Manag; 2007; 3(1):159-64. PubMed ID: 17583186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
    Warnholtz A; Wild P; Ostad MA; Elsner V; Stieber F; Schinzel R; Walter U; Peetz D; Lackner K; Blankenberg S; Munzel T
    Atherosclerosis; 2009 May; 204(1):216-21. PubMed ID: 18822413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg.
    Wi J; Kim JY; Park S; Kang SM; Jang Y; Chung N; Shim WH; Cho SY; Lee SH
    Atherosclerosis; 2010 Nov; 213(1):235-40. PubMed ID: 20855072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of niacin on glucose control in patients with dyslipidemia.
    Goldberg RB; Jacobson TA
    Mayo Clin Proc; 2008 Apr; 83(4):470-8. PubMed ID: 18380993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
    Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T
    JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
    Li XP; Duan J; Zhao SP; Tan MY; Xu ZM; Zhang DQ
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2399-403. PubMed ID: 17156651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression.
    Kuvin JT; Rämet ME; Patel AR; Pandian NG; Mendelsohn ME; Karas RH
    Am Heart J; 2002 Jul; 144(1):165-72. PubMed ID: 12094204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).
    Zhao XQ; Morse JS; Dowdy AA; Heise N; DeAngelis D; Frohlich J; Chait A; Albers JJ; Brown BG
    Am J Cardiol; 2004 Feb; 93(3):307-12. PubMed ID: 14759379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus.
    Garg A; Grundy SM
    JAMA; 1990 Aug; 264(6):723-6. PubMed ID: 2374275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.
    Pan J; Shilian P; Ishida B; Wu X; Kane JP; Malloy MJ; Charles MA
    Metabolism; 2011 Feb; 60(2):292-7. PubMed ID: 20303127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol.
    Toth PP; Zarotsky V; Sullivan JM; Laitinen D
    Curr Med Res Opin; 2009 Jun; 25(6):1355-63. PubMed ID: 19425901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients.
    Tsalamandris C; Panagiotopoulos S; Sinha A; Cooper ME; Jerums G
    J Cardiovasc Risk; 1994 Oct; 1(3):231-9. PubMed ID: 7621303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.